Literature DB >> 23091581

Lobomycosis: A case from Southeastern Europe and review of the literature.

Evangelia Papadavid1, Maria Dalamaga, Irini Kapniari, Ekaterini Pantelidaki, Sotirios Papageorgiou, Vassiliki Pappa, Panagiotis Tsirigotis, Ioannis Dervenoulas, Nikolaos Stavrianeas, Dimitrios Rigopoulos.   

Abstract

BACKGROUND: Lobomycosis, also known as Jorge Lobo's disease, represents a rare chronic subcutaneous mycosis caused by the fungus Lacazia loboi, an organism that is found within lesions but has not been cultured to date. The natural reservoir of L. loboi is unknown but it is believed to be aquatic, or associated with soil and vegetation. More than 550 human cases have been reported, especially in patients with a history of travel or residence in endemic areas (Central and South America, particularly Brazil) or in communities along rivers. MAIN OBSERVATIONS: We describe a 64-year-old Greek female farmer living in a coastal region, who presented with an erythematous plaque on her left inner thigh resembling a keloid. The diagnosis was based on the triad: 1) absence of fungal growth in cultures, 2) positive direct microscopic examination of the lesion and 3) histopathology, all consistent with lobomycosis. Particularly, skin biopsy showed deep cutaneous fungal infection with granulomatous reaction. Fungal cells were found inside giant cells. The fungi were thick-walled with some budding, isolated or in short chains. Dermal fibrosis was present. Our patient had a medical history of common variable immunodeficiency but no history of travel to South or Central America. She probably acquired this rare infection by injury during her agricultural works.
CONCLUSION: Our case represents probably the first documented case of human lobomycosis in Southeastern Europe. This case is unusual due to the rarity of lobomycosis in Mediterranean countries, particularly in Southeastern Europe.

Entities:  

Keywords:  Lacazia loboi; Lobo’s disease; immunodeficiency; infection; lacaziosis; lobomycosis; mycosis

Year:  2012        PMID: 23091581      PMCID: PMC3470791          DOI: 10.3315/jdcr.2012.1104

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  33 in total

1.  Lobomycosis in three Venezuelan patients.

Authors:  A M Brun
Journal:  Int J Dermatol       Date:  1999-04       Impact factor: 2.736

Review 2.  Subcutaneous fungal infections.

Authors:  Katie R Pang; Jashin J Wu; David B Huang; Stephen K Tyring
Journal:  Dermatol Ther       Date:  2004       Impact factor: 2.851

Review 3.  Lobomycosis in Venezuela.

Authors:  Alberto E Paniz-Mondolfi; Oscar Reyes Jaimes; Luisana Dávila Jones
Journal:  Int J Dermatol       Date:  2007-02       Impact factor: 2.736

4.  [Sucessful treatment with clofazimine and itraconazole in a 46 year old patient after 32 years duration of disease].

Authors:  M Fischer; A Chrusciak Talhari; D Reinel; S Talhari
Journal:  Hautarzt       Date:  2002-10       Impact factor: 0.751

5.  Macrophage and TGF-beta immunohistochemical expression in Jorge Lobo's disease.

Authors:  Marilia Brasil Xavier; Rosana Maria Feio Libonati; Débora Unger; Clívia Oliveira; Carlos Eduardo Pereira Corbett; Arival Cardoso de Brito; Juarez Antonio Simões Quaresma
Journal:  Hum Pathol       Date:  2007-10-24       Impact factor: 3.466

6.  Lobomycosis in African patients.

Authors:  W I Al-Daraji; E Husain; A Robson
Journal:  Br J Dermatol       Date:  2008-07-01       Impact factor: 9.302

7.  Lobo's disease in an atlantic bottle-nosed dolphin.

Authors:  G Migaki; M G Valerio; B Irvine; F M Garner
Journal:  J Am Vet Med Assoc       Date:  1971-09       Impact factor: 1.936

8.  A possible case of Lôbo's disease acquired in Europe from a bottle-nosed dolphin (Tursiops truncatus).

Authors:  W S Symmers
Journal:  Bull Soc Pathol Exot Filiales       Date:  1983-12

Review 9.  Lobomycosis. Literature review and future perspectives.

Authors:  M Ramos-E-Silva; F Aguiar-Santos-Vilela; A Cardoso-de-Brito; S Coelho-Carneiro
Journal:  Actas Dermosifiliogr       Date:  2009-11

10.  Immunohistochemical study of Langerhans cells in cutaneous lesions of the Jorge Lobo's disease.

Authors:  Juarez Antonio Simoes Quaresma; Debora Unger; Carla Pagliari; Mirian Nacagami Sotto; Maria Irma Seixas Duarte; Arival Cardoso de Brito
Journal:  Acta Trop       Date:  2010-01-04       Impact factor: 3.112

View more
  9 in total

Review 1.  Lobomycosis Epidemiology and Management: The Quest for a Cure for the Most Neglected of Neglected Tropical Diseases.

Authors:  Franciely G Gonçalves; Patrícia S Rosa; Andrea de F F Belone; Léia B Carneiro; Vania L Q de Barros; Rosineide F Bispo; Yally A da S Sbardelott; Sebastião A V M Neves; Amy Y Vittor; William J Woods; Gabriel Z Laporta
Journal:  J Fungi (Basel)       Date:  2022-05-10

Review 2.  Lobomycosis: risk of zoonotic transmission from dolphins to humans.

Authors:  John S Reif; Adam M Schaefer; Gregory D Bossart
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-06       Impact factor: 2.133

3.  Case Report: Molecular Confirmation of Lobomycosis in an Italian Traveler Acquired in the Amazon Region of Venezuela.

Authors:  Anna Beltrame; Patrizia Danesi; Claudio Farina; Pierantonio Orza; Francesca Perandin; Claudia Zanardello; Paola Rodari; Silvia Staffolani; Zeno Bisoffi
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

4.  Jorge Lobo's disease.

Authors:  Kalline Andrade de Carvalho; Marcos César Floriano; Milvia Maria Simões e Silva Enokihara; Marta Regina Machado Mascarenhas
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

Review 5.  Lobomycosis: epidemiology, clinical presentation, and management options.

Authors:  Valeska Albuquerque Francesconi; Ana Paula Klein; Ana Paula Botelho Gualda Santos; Rajendranath Ramasawmy; Fábio Francesconi
Journal:  Ther Clin Risk Manag       Date:  2014-10-09       Impact factor: 2.423

6.  Lobomycosis in Soldiers, Colombia.

Authors:  Claudia M Arenas; Gerzain Rodriguez-Toro; Andrea Ortiz-Florez; Ingrid Serrato
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

7.  Epidemiologic and Clinical Progression of Lobomycosis among Kaiabi Indians, Brazil, 1965-2019.

Authors:  Marcos C Florian; Douglas A Rodrigues; Sofia B M de Mendonça; Arnaldo L Colombo; Jane Tomimori
Journal:  Emerg Infect Dis       Date:  2020-05       Impact factor: 6.883

8.  Analysis of Immune Response Markers in Jorge Lobo's Disease Lesions Suggests the Occurrence of Mixed T Helper Responses with the Dominance of Regulatory T Cell Activity.

Authors:  Michelle de C S Azevedo; Patricia S Rosa; Cleverson T Soares; Luciana R V Fachin; Ida Maria F D Baptista; William J Woods; Gustavo P Garlet; Ana Paula F Trombone; Andrea de F F Belone
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

9.  Lobomycosis: a therapeutic challenge.

Authors:  Marcelo Grossi Araújo; Nathalie Silva Cirilo; Soraya Neves Marques Barbosa Dos Santos; Claudemir Roberto Aguilar; Antonio Carlos Martins Guedes
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.